SCHEMBL6566504

SCHEMBL6566504

CCC(O)(CC)c1ccc(-c2csc(COc3ccc(CO)c(CO)c3)c2)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
VDR P11473 3/20 0.50
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564065 0.91 VDR (0.56) VDR
SCHEMBL6566427 0.82 VDR (0.51) VDR
SCHEMBL6566493 0.82 VDR (0.51) VDR
SCHEMBL6563004 0.82 VDR (0.51) VDR
SCHEMBL6564145 0.82 VDR (0.55) VDR
SCHEMBL6564130 0.81 VDR (0.60) VDR
SCHEMBL6563025 0.80 VDR (0.58) VDR
SCHEMBL6562993 0.80 VDR (0.65) VDR
SCHEMBL7610475 0.79 VDR (0.32) VDRACACBACACA
SCHEMBL7610479 0.78 VDR (0.35) VDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235777-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2004-06-16 EP claimed
US-6831106-B1 Selective activity on cell proliferation and differentiation without displaying any hypercalcaemiant nature GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2004-12-14 US disclosed